Share Price:

APNASPENAspen Pharmacare Hldgs13541-11 (-0.08%)

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

Aspen North America Region’s Aspen Canada certified as a Great Place to Work®

Aspen Canada started 2026 on a high, by being officially certified as a Great Place to Work® — a global recognition awarded to organisations based on employee feedback and workplace culture.

Aspen launches its 2025 Integrated Report and retains Level 4 B-BBEE status

We’re proud to announce the release of our 2025 Integrated Report and Supplementary Documents, showcasing how Aspen continues to deliver on its purpose — improving the health and quality of life of patients while creating sustainable value for our stakeholders.

Aspen continues to demonstrate its unwavering commitment to our various communities

On 15 September 2025, Stavros Nicolaou, Group Senior Executive: Strategic Trade, joined by the South African Minister of Sport, Arts and Culture, Mr. Gayton McKenzie, officially handed over Aspen-sponsored netball courts to the Ennerdale community — a community with a wide range of socioeconomic challenges and in many respects neglected.

Aspen partners with Reach for a Dream to bring joy to children with rare diseases 

Turning Dreams into Reality with Reach for A Dream

Aspen recognised for EY Excellence in Integrated Reporting Award

In September, Aspen once again earned recognition in Integrated Reporting – after receiving the EY Excellence in Integrated Reporting Award.

Stakeholder Update Call Webcast 15 January 2026

View Online

FY 2025 Annual Financial Statements

View or Download

H1 2025 Interim Results Booklet

View or Download

H1 2025 Interim Results Presentation

View or Download

Stakeholder Notes – 23 April 2025

View or Download

SENS 29 December 2025

View or Download

Aspen and Lilly enter into agreement in South Africa and the rest of Sub-Saharan Africa

Stephen Saad, Aspen Group Chief Executive

Subject to approval from relevant Competition Authorities, Lilly will enter a strategic agreement with Aspen to continue serving patients and bring innovative therapies to South Africa and the rest of Sub-Saharan Africa. Johannesburg – In an effort to improve the reach and expand the access of its innovative portfolio of medicines to the patients who… Continue reading Aspen and Lilly enter into agreement in South Africa and the rest of Sub-Saharan Africa

Closed Period

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Corporate

Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.

View our teams below: